AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review

  • ID: 1314893
  • SWOT Analysis
  • 81 pages
  • GlobalData
  • Astrazeneca PLC
1 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Astellas Pharma Inc
  • Daiichi Sankyo Co Ltd
  • Gilead Sciences Inc
  • Johnson & Johnson
  • Novartis AG
  • MORE
AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases. It is also developing new approaches to the treatment of asthma. The company’s product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in Cambridge, Cambridgeshire, the UK.

AstraZeneca Plc Key Recent Developments

Mar 14, 2018: New collaboration for Nottingham is UKs first for a Biomedical Research Centre
Mar 08, 2018: Eliminating Cost Barriers Helps Heart Patients Comply with Drug Regimens
Mar 05, 2018: AstraZeneca aims to advance clinical practice in CV risk management with new data at ACC 2018
Feb 08, 2018: Onglyza Heart Failure Lawsuits Centralized in Kentucky Federal Court, Bernstein Liebhard Reports
Feb 05, 2018: Brooks Life Sciences Helps Revolutionize Compound Management with the Launch of New FluidX AcoustiX Sample Tube

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Astellas Pharma Inc
  • Daiichi Sankyo Co Ltd
  • Gilead Sciences Inc
  • Johnson & Johnson
  • Novartis AG
  • MORE
Section 1 - About the Company
  • AstraZeneca Plc - Key Facts
  • AstraZeneca Plc - Key Employees
  • AstraZeneca Plc - Key Employee Biographies
  • AstraZeneca Plc - Major Products and Services
  • AstraZeneca Plc - History
  • AstraZeneca Plc - Company Statement
  • AstraZeneca Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • AstraZeneca Plc - Business Description
  • Business Segment: Biopharmaceuticals
  • Overview
  • Performance
  • Business Segment: Externalisation Revenue
  • Overview
  • Performance
  • Geographical Segment: Asia, Africa & Australasia
  • Performance
  • Geographical Segment: Continental Europe
  • Performance
  • Geographical Segment: The Americas
  • Performance
  • Geographical Segment: the UK
  • Performance
  • R&D Overview
  • AstraZeneca Plc - Corporate Strategy
  • AstraZeneca Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • AstraZeneca Plc - Strengths
  • AstraZeneca Plc - Weaknesses
  • AstraZeneca Plc - Opportunities
  • AstraZeneca Plc - Threats
  • AstraZeneca Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • AstraZeneca Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 14, 2018: New collaboration for Nottingham is UKs first for a Biomedical Research Centre
  • Mar 08, 2018: Eliminating Cost Barriers Helps Heart Patients Comply with Drug Regimens
  • Mar 05, 2018: AstraZeneca aims to advance clinical practice in CV risk management with new data at ACC 2018
  • Feb 08, 2018: Onglyza Heart Failure Lawsuits Centralized in Kentucky Federal Court, Bernstein Liebhard Reports
  • Feb 05, 2018: Brooks Life Sciences Helps Revolutionize Compound Management with the Launch of New FluidX AcoustiX Sample Tube
  • Feb 02, 2018: AstraZeneca: Full-Year 2017 Results
  • Feb 01, 2018: Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure
  • Feb 01, 2018: ACT Genomics, AstraZeneca enter Collaboration for BRCA Testing in Singapore and Taiwan
  • Jan 25, 2018: ACT Genomics collaborates with AstraZeneca on BRCA testing
  • Jan 24, 2018: A New Ecosystem Approach to Fight Antibiotic Resistance
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • AstraZeneca Plc, Key Facts
  • AstraZeneca Plc, Key Employees
  • AstraZeneca Plc, Key Employee Biographies
  • AstraZeneca Plc, Major Products and Services
  • AstraZeneca Plc, History
  • AstraZeneca Plc, Subsidiaries
  • AstraZeneca Plc, Joint Venture
  • AstraZeneca Plc, Key Competitors
  • AstraZeneca Plc, Ratios based on current share price
  • AstraZeneca Plc, Annual Ratios
  • AstraZeneca Plc, Annual Ratios
  • AstraZeneca Plc, Annual Ratios
  • AstraZeneca Plc, Interim Ratios
  • AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • AstraZeneca Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • AstraZeneca Plc, Performance Chart (2013 - 2017)
  • AstraZeneca Plc, Ratio Charts
  • AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Takeda Pharmaceutical Co Ltd
  • Shire Plc
  • Sanofi
  • Pfizer Inc
  • Novo Nordisk AS
  • Novartis AG
  • Merck & Co Inc
  • Johnson & Johnson
  • GlaxoSmithKline Plc
  • Gilead Sciences Inc
  • F. Hoffmann-La Roche Ltd
  • Daiichi Sankyo Co Ltd
  • Bristol-Myers Squibb Co
  • Astellas Pharma Inc
  • Amgen Inc
  • AbbVie Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll